DARE

Dare Bioscience Inc

• TipRanks·1d ago

  Daré Bioscience Releases New Investor Corporate Presentation

• Benzinga·5d ago

  12 Health Care Stocks Moving In Monday's Intraday Session

• TipRanks·07/17 21:32

  Daré Bioscience Faces Nasdaq Listing Compliance Challenges

• TipRanks·07/17 16:31

  Daré Bioscience Advances DARE-HPV Trial, Raising New Questions for HPV Treatment Investors

• TipRanks·07/13 17:25

  Daré Bioscience Updates Investors With New Presentation

• TipRanks·06/22 14:00

  Daré Bioscience Issues New Corporate Investor Presentation

• PUBT·06/18 13:20

  Daré Bioscience CEO speaks at BIO International Convention 2026

• TipRanks·06/12 21:42

  Daré Bioscience Shareholders Back Governance and Capital Plans

• PUBT·06/12 20:01

  Daré Bioscience shareholders approve 1.5 million-share increase to 2022 stock incentive plan at annual meeting

• Reuters·06/04 12:00

  DARÉ BIOSCIENCE ANNOUNCES THE UPCOMING LAUNCH OF FLORA SYNC LF5™ VAGINAL PROBIOTIC CAPSULES

• TipRanks·05/26 12:19

  Dare Bioscience receives NIH funding award notice to advance DARE-HPV

• Benzinga·05/26 12:15

  Dare Biosciences Receives Second $1M Tranche Of NIH Funding

• PUBT·05/26 12:06

  Daré Bioscience wins $1 million NIH grant tranche for DARE-HPV program

• Reuters·05/26 12:00

  DARÉ BIOSCIENCE RECEIVES NIH FUNDING AWARD NOTICE TO ADVANCE DARE-HPV, ITS NOVEL INVESTIGATIONAL TREATMENT FOR PERSISTENT HIGH-RISK HPV INFECTION, THE MOST COMMON CAUSE OF CERVICAL CANCER

• Dow Jones·05/26 12:00

  Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer